PRELLIS IN THE MEDIA
Prellis Biologics, Inc. Generates 300 Human Antibodies That Bind the SARS-CoV2 Virus; Pursues Development of a Treatment and Preventative Therapy for COVID-19 Infection
Business Wire
Prellis Biologics Pursues Bioprinted Lymph Nodes for Production of COVID-19 Antibodies
3DPrint.com
3DHEALS Jenny Chen Interviews Gavan Wilhite: 3DHEALS2020 Software Design Interview
3DHEALS
